Unterehmen auf Watchlist setzen
Becton Dickinson
ISIN: US0758871091
WKN: 857675
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Becton Dickinson · ISIN: US0758871091 · PR Newswire (ID: 20240703NY53634)
03 Juli 2024 02:30PM

BD to Announce Financial Results for its Third Quarter of Fiscal 2024


FRANKLIN LAKES, N.J., July 3, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2024 on Thursday, August 1, 2024. A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's third quarter of fiscal year 2024, which ended on June 30, 2024.

BD management will host an audio webcast at 8 a.m. ET on August 1, 2024 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson

Contacts:







Media:                                             

Investors:

Troy Kirkpatrick                                 

Adam Reiffe

VP, Public Relations                       

Sr. Director, Investor Relations

858.617.2361                                

201.847.6927       

troy.kirkpatrick@bd.com              

adam.reiffe@bd.com     

 

Cision View original content:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-third-quarter-of-fiscal-2024-302188455.html

SOURCE BD (Becton, Dickinson and Company)

Visuelle Wertentwicklung / Kursverlauf · Becton Dickinson
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942